At Soin et Nature, trust the pharmaceutical expertise of Ipsen, a leading French pharmaceutical company committed to developing innovative medicines to treat serious diseases and bring about lasting improvements in patients’ quality of life. Through rigorous clinical research and a constant commitment to quality, Ipsen offers therapeutic solutions that are effective, safe, and tailored to the specific needs of each patient.
More detailsSince its founding in 1929 in Dreux (Eure-et-Loir), Ipsen Laboratoire has embodied French excellence in the pharmaceutical field. This family-owned company, which has grown into an international player, draws on nearly a century of experience to meet patients’ healthcare needs. With its headquarters in Boulogne-Billancourt (Hauts-de-Seine) and strategic research and production sites throughout France, Ipsen remains firmly rooted in its home region while expanding its reach worldwide.
Ipsen is recognized for its expertise in three priority therapeutic areas: oncology, rare diseases, and neuroscience. These therapeutic areas, often overlooked by other companies, represent unmet medical needs for millions of patients. The company’s ambition is clear: to provide innovative, high-quality treatments that truly transform patients’ lives.
At the heart of Ipsen’s philosophy lies a deep commitment to innovation. The company has developed strategic partnerships with French biotechnology firms, such as GENFIT and AGV Discovery, to foster the development of cutting-edge treatments. Ipsen is also an active investor in the Innobio 1 and 2 funds, which support biomedical research in France.
This commitment to innovation extends beyond scientific discoveries. As a founding sponsor of Biolabs—Europe’s second-largest innovation hub, located at the Hôtel-Dieu Hospital (AP-HP)—Ipsen actively supports biotechnology startups. This collaboration exemplifies the company’s goal: to contribute to the development of a dynamic and sustainable medical ecosystem.
The Signes (Var) manufacturing site perfectly exemplifies Ipsen’s pursuit of excellence. In 2021, this site was honored with the Shingo d’Or Award, a prestigious accolade recognizing operational performance and industrial innovation. Producing nearly 60% of the group’s medications by value, the Signes site plays a central role in supplying patients, with exports to more than 70 countries.
Ipsen’s operational excellence is also reflected in rigorous quality control. Each medication is carefully formulated in accordance with strict standards to ensure product safety and efficacy. This reflects a simple philosophy: to provide patients with treatments they can rely on, regardless of their health conditions.
Ipsen does more than just produce medicines; the company is actively committed to a sustainable future. Its sustainability strategy is based on four pillars: the environment, patients, employees, and governance. In environmental matters, Ipsen applies international standards such as ISO 14001-2015 to minimize its environmental footprint, and ISO 45001-2018 to ensure the safety of its employees.
Furthermore, Ipsen strives to limit the risk of incidents and accidents at its sites, while adopting an ethical approach to managing its operations. These actions reflect a comprehensive vision: to preserve the planet while improving patients’ health and quality of life.
In short, Ipsen is much more than just a pharmaceutical company. With its commitment to innovation, excellence, and sustainability, Ipsen is a trusted partner for patients, healthcare professionals, and communities.
Ipsen offers a comprehensive range of medications designed to address a variety of needs, from gastrointestinal disorders and chronic pain to more complex conditions. Here is a detailed overview of the brand’s flagship products:
These products demonstrate Ipsen’s expertise in digestive, neurological, and general health. Each product line is developed to offer reliable solutions tailored to patients’ specific needs.
Ipsen is constantly evolving to anticipate the challenges of tomorrow. Through its investments in research and collaborations with innovative partners, the company develops targeted treatments that significantly improve patients’ lives.
Its commitment to sustainability is equally remarkable. By implementing initiatives to reduce its carbon footprint, improve resource management, and promote community health, Ipsen is taking a resolutely forward-looking approach.
By choosing Ipsen, you are choosing a pharmaceutical company that combines medical expertise, environmental responsibility, and social commitment. This is the promise of a company that places patient well-being at the heart of its mission, while working toward a more sustainable world.
